(Q44635214)

4 December 2017

title

Endocrine and cytokine responses to standardized physical stress in multiple sclerosis (English)

1 reference

4 December 2017

2

1 reference

4 December 2017

Christoph Heesen

1

1 reference

4 December 2017

Sten Hartmann

3

1 reference

4 December 2017

Mila Mladek

4

1 reference

4 December 2017

Rüdiger Reer

5

1 reference

4 December 2017

Klaus-Michael Braumann

6

1 reference

4 December 2017

Klaus Wiedemann

7

1 reference

4 December 2017

Karl-Heinz Schulz

8

1 reference

4 December 2017

publication date

1 December 2003

1 reference

Brain, Behavior, and Immunity

4 December 2017

published in

1 reference

4 December 2017

volume

17

1 reference

4 December 2017

issue

6

1 reference

4 December 2017

page(s)

473-481

1 reference

Stressor-induced alteration of cytokine production in multiple sclerosis patients and controls

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2803%2900077-1

7 January 2021

Stressful life events precede exacerbations of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2803%2900077-1

7 January 2021

Acute stress shortens the time to onset of experimental allergic encephalomyelitis in SJL/J mice

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2803%2900077-1

7 January 2021

Increased circulating cytokine receptors and ex vivo interleukin-1 receptor antagonist and interleukin-1beta production but decreased tumour necrosis factor-alpha production after a 5-km run

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2803%2900077-1

7 January 2021

Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2803%2900077-1

7 January 2021

Mood disorders and dysfunction of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: association with cerebral inflammation.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2803%2900077-1

7 January 2021

The relationship of MS to physical trauma and psychological stress: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2803%2900077-1

7 January 2021

Endocrine and cytokine responses to acute psychological stress in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2803%2900077-1

7 January 2021

Cognitive impairment correlates with hypothalamo-pituitary-adrenal axis dysregulation in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2803%2900077-1

7 January 2021

Oral terbutaline differentially affects cytokine (IL-10, IL-12, TNF, IFNg) release in multiple sclerosis patients and controls

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2803%2900077-1

7 January 2021

Exercise and the immune system: a model of the stress response?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2803%2900077-1

7 January 2021

The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2803%2900077-1

7 January 2021

Hormonal responses to exercise and training: a short review

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2803%2900077-1

7 January 2021

Adrenal medulla and exercise training

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2803%2900077-1

7 January 2021

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2803%2900077-1

7 January 2021

Effect of physical exercise on adoptive experimental auto-immune encephalomyelitis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2803%2900077-1

7 January 2021

Defining the clinical course of multiple sclerosis: Results of an international survey

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2803%2900077-1

7 January 2021

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2803%2900077-1

7 January 2021

Multiple sclerosis is associated with alterations in hypothalamic-pituitary-adrenal axis function.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2803%2900077-1

7 January 2021

Effects of a short-term exercise training program on aerobic fitness, fatigue, health perception and activity level of subjects with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2803%2900077-1

7 January 2021

Problems with rating scales for multiple sclerosis: a novel approach--the CAMBS score

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2803%2900077-1

7 January 2021

Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2803%2900077-1

7 January 2021

A trauma-like elevation of plasma cytokines in humans in response to treadmill running

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2803%2900077-1

7 January 2021

Exercise and the immune system: regulation, integration, and adaptation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2803%2900077-1

7 January 2021

Impact of aerobic training on fitness and quality of life in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2803%2900077-1

7 January 2021

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2803%2900077-1

7 January 2021

Catecholamine levels in peripheral blood lymphocytes from multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2803%2900077-1

7 January 2021

Dysregulation of the hypothalamo-pituitary-adrenal axis is related to the clinical course of MS.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2803%2900077-1

7 January 2021

Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2803%2900077-1

7 January 2021

Plasma Hormones and Physical Exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2803%2900077-1

7 January 2021

The neuroendocrine axis in patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2803%2900077-1

7 January 2021

Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2803%2900077-1

7 January 2021

beta-Adrenergic receptor density and function of peripheral blood mononuclear cells are increased in multiple sclerosis: a regulatory role for cortisol and interleukin-1

1 reference

https://api.crossref.org/works/10.1016%2FS0889-1591%2803%2900077-1

7 January 2021

10.1016/S0889-1591(03)00077-1

Identifiers

DOI

1 reference

4 December 2017

1 reference